Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as an injectable solution for intraarterial, intraarticular and intrathecal administration. It enhances X‑ray attenuation, providing radiographic contrast that improves visualization of vessels, joints, the spinal canal and other anatomical structures during angiography, arthrography, myelography and general imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets with reliable logistics, quality assurance, and regulatory support.

Iomeron, an iodinated contrast agent, is employed to enhance X‑ray based imaging across several clinical applications. - Vascular imaging (angiography): improves delineation of blood vessels and vascular pathology. - Arthrography: enhances joint space visualization for diagnostic assessment. - Myelography: provides clear contrast of the spinal canal and nerve roots. - General radiographic procedures: increases soft‑tissue contrast in CT and fluoroscopic studies.

Iomeron may be associated with a range of adverse reactions, varying from mild and transient to severe and potentially life‑threatening. Common Side Effects: - Warmth or flushing sensation - Metallic taste - Mild nausea or vomiting - Headache - Transient urticaria or itching - Injection site pain or discomfort Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute kidney injury or renal impairment - Thyroid dysfunction (hyper‑ or hypothyroidism) - Seizures or neurological events - Cardiac arrhythmias - Pulmonary edema or respiratory distress

Prior to administering Iomeron, clinicians should observe specific precautions to minimize risk and ensure patient safety. - Assess renal function: evaluate serum creatinine and eGFR before use. - Review allergy history: identify prior reactions to iodinated contrast or related agents. - Use lowest effective dose: tailor volume to the specific imaging study. - Monitor thyroid status: consider in patients with known thyroid disease. - Avoid in patients with documented severe hypersensitivity to iodinated contrast media. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with other medicines, influencing safety or efficacy; awareness of major and moderate interactions guides clinical decisions. Major Interactions (Avoid): - Concurrent administration of other iodinated contrast agents. - Nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs) in patients with impaired renal function. - Thyroid hormone therapy in uncontrolled hyperthyroidism. - Radiopharmaceuticals containing iodine that may alter diagnostic accuracy. - Metformin in patients with reduced renal clearance (risk of lactic acidosis). Moderate Interactions (Monitor Closely): - Loop diuretics: may affect fluid balance and contrast elimination. - ACE inhibitors or ARBs: can potentiate renal effects of contrast. - Calcium channel blockers: monitor blood pressure changes. - Beta‑blockers: observe for altered hemodynamic response. - Anticoagulants: increased bleeding risk with intrathecal administration.